Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Ocular Therapeutix (OCUL)

April 30, 2026 6:54 AM EDT Send to a Friend
H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $21.00 price target on Ocular Therapeutix (NASDAQ: OCUL).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login